Stroke and atrial fibrillation: An update
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. AF is associated with an increased risk of cardiovascular disease, heart failure, stroke, cognitive impairment and dementia, and mortality. Individuals with AF have a 5-fold risk of ischemic st...
Main Authors: | Nicole Beaton Sur, Jose G. Romano |
---|---|
Format: | Article |
Language: | English |
Published: |
Permanyer
2022-10-01
|
Series: | Revista Mexicana de Neurociencia |
Subjects: | |
Online Access: | https://www.revmexneurociencia.com/frame_esp.php?id=190 |
Similar Items
-
Secondary Precipitants of Atrial Fibrillation and Anticoagulation Therapy
by: Darae Ko, et al.
Published: (2021-11-01) -
Anticoagulant therapy for the prevention of recurrent stroke in patients with atrial fibrillation: a comprehensive risk management
by: V. A. Sorokoumov
Published: (2022-01-01) -
Anticoagulation initiation after non ⁃ valvular atrial fibrillation with acute ischemic stroke
by: LU Feng⁃min, et al.
Published: (2024-02-01) -
PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01) -
Anticoagulant therapy as a part of secondary stroke prevention in patients with atrial fibrillation
by: O. D. Ostroumova, et al.
Published: (2022-06-01)